These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15334622)

  • 1. Acetylation phenotype status in a Bangladeshi population and its comparison with that of other Asian population data.
    Zaid RB; Nargis M; Neelotpol S; Hannan JM; Islam S; Akhter R; Ali L; Azad Khan AK
    Biopharm Drug Dispos; 2004 Sep; 25(6):237-41. PubMed ID: 15334622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of acetylator phenotype in the identity of Asian populations.
    Zaid RB; Nargis M; Neelotpol S; Sayeed MA; Banu A; Shurovi S; Hassan KN; Salimullah M; Ali L; Azad Khan AK
    Hum Biol; 2007 Jun; 79(3):363-8. PubMed ID: 18078208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predominance of slow acetylators of N-acetyltransferase in a Hmong population residing in the United States.
    Straka RJ; Hansen SR; Benson SR; Walker PF
    J Clin Pharmacol; 1996 Aug; 36(8):740-7. PubMed ID: 8877679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England.
    Welfare MR; Cooper J; Bassendine MF; Daly AK
    Carcinogenesis; 1997 Jul; 18(7):1351-4. PubMed ID: 9230278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between serum isonicotinic acid hydrazide (INH) levels and urinary sulfadimidine (sulfamethazine) acetylation as predictors of INH acetylator status.
    Seth V; Seth SD; Beotra A; Singh U
    Dev Pharmacol Ther; 1988; 11(1):32-6. PubMed ID: 3383719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation.
    Weber WW
    Birth Defects Orig Artic Ser; 1990; 26(1):43-65. PubMed ID: 2224079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylation phenotyping with sulphadimidine in a Turkish population.
    Bozkurt A; Basci NE; Kalan S; Tuncer M; Kayaalp SO
    Eur J Clin Pharmacol; 1990; 38(1):53-6. PubMed ID: 2328748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of phenotype and genotype of NAT2 deficiency in Chinese populations.
    Xie HG; Xu ZH; Ou-Yang DS; Shu Y; Yang DL; Wang JS; Yan XD; Huang SL; Wang W; Zhou HH
    Pharmacogenetics; 1997 Dec; 7(6):503-14. PubMed ID: 9429236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine as a potential indicator for acetylator status.
    Rankin RB; Hudson SA; Fell AF
    J Clin Pharm Ther; 1987 Feb; 12(1):47-51. PubMed ID: 3449563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylator phenotype in patients with breast cancer.
    Bulovskaya LN; Krupkin RG; Bochina TA; Shipkova AA; Pavlova MV
    Oncology; 1978; 35(4):185-8. PubMed ID: 704038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between serum and urinary sulphadimidine acetylation as predictors of isoniazid acetylator status in patients with pulmonary tuberculosis.
    Singh SP; Pande JN; Khilnani GC; Kailash S
    Indian J Chest Dis Allied Sci; 1996; 38(1):5-11. PubMed ID: 16892742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine acetylation may be effected by acetyltransferases other than NAT1 or NAT2.
    Bras AP; Hoff HR; Aoki FY; Sitar DS
    Can J Physiol Pharmacol; 1998; 76(7-8):701-6. PubMed ID: 10030449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
    Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
    J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoniazid acetylation phenotyping in Saudi Arabs.
    Matar KM; Mayet AY; Ayoola EA; Bawazir SA; Al-Faleh FZ; Al-Wazzan A
    J Clin Pharm Ther; 2004 Oct; 29(5):443-7. PubMed ID: 15482388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human acetylator polymorphism: estimate of allele frequency in Libya and details of global distribution.
    Karim AK; Elfellah MS; Evans DA
    J Med Genet; 1981 Oct; 18(5):325-30. PubMed ID: 7328611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of the rapid isoniazid acetylator phenotype in Lagos (Nigeria).
    Odeigah PG; Okunowo MA
    Hum Hered; 1989; 39(1):26-31. PubMed ID: 2759621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.